MedTrace Logo

Assessment of Pupil Light Responses in Patients With Parkinson Disease

NCT04117555 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-11-22

No results posted yet for this study

Summary

Parkinson diseases (PD) is the second most common degenerative disease of the central nervous system. The development of early diagnostic biomarkers may help identify at-risk individuals and allow precocious interventions at the onset of disease and more precise monitoring of therapies that may slow disease progression.

Proof of concept studies indicated significant differences in pupil light response between PD patients and healthy controls. The feasibility of using pupillometry for assesment of PD will be examined.

Conditions

  • Parkinson Disease

Interventions

DIAGNOSTIC_TEST

Pupil response to light stimuli

Objective and accurate measurement of pupillary responses to light stimuli

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Sharon Hassin-Baer, Prof. · Sheba Medical Center

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117555 on ClinicalTrials.gov